View Document Preview and Link Document Date: 2012-02-06 05:39:14 Open Document File Size: 671,02 KB Share Result on Facebook
Country Japan / United States / Canada / / IndustryTerm bioreactor systems / chemical domain / test chemicals / exogenous chemicals / content analysis tools / pharmaceuticals / chemical categories / wider chemical space / reference chemicals / safety assessment context chemoinformatics tools / nervous systems / assay systems / differentiation protocols / chemical activity/effect levels / Experimental and computational tools / decision support systems / predictive toxicology tools / biological systems / scientific tools / well studied chemicals / prediction algorithms / important computational and experimental tools / integrated toxicological hazard prediction systems / chemical / molecular imaging / content functional analysis tools / chemical safety assessment paradigm / chemical type / imaging / computational tools / chemicals / stem cell technology / chemical fate / microelectronic and optical biosensing technology / predictive tools / predictive systems / / MedicalCondition cancer / chronic toxicological action / disease / tumour / chronic low-dose effects / chronic systemic toxicity / / Organization World Health Organization / Nuclear Regulatory Commission / European Cosmetics Association / US Federal Reserve / European Commission / European Union / Health Directorate / OECD / / Person Michael Schwarz / Maurice Whelan / / Position Directorate General for Research / Reporter / / Technology proteomics / differentiated stem Exploit stem cell technology / transcriptomics / microelectronic and optical biosensing technology / differentiation protocols / chemoinformatics / Bioreactor technology / stem cells / prediction algorithms / / SocialTag 
SEURAT-1 Strategy Paper Maurice Whelan, Michael Schwarz, and the Scientific Expert Panel of the SEURAT-1 Research Initiative. “The goal of mode-of-action, human biology-based testing is not to generate batteries of